Orin Hirschman 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-17 4:10 pm Sale | 2021-03-12 | 13G | NLS Pharmaceutics AG NLSP | Orin Hirschman | 14,430 4.900% | -8,570 (-37.26%) | Filing |
| 2021-02-04 06:30 am Purchase | 2021-01-29 | 13G | NLS Pharmaceutics AG NLSP | Orin Hirschman | 23,000 7.800% | 23,000 (New Position) | Filing |